Skip to main content

Table 1 The main characteristics of the included studies

From: Dose–effect relationship of stereotactic body radiotherapy in non-small cell lung cancer patients

First author (year)

Country

Study design

Treatment time

N

Male/female

Operable

Age

Immobilization and breath control

CTV/ITV delineation

PTV margin (mm)

Nominal/central/peripheral dose (Gy)

Fractions

Interval time

Treatment equipment

THC

Nominal/central/peripheral/average BED (Gy)

Median follow-up (m)

3-years local control (%)

Baumann (2009) [9]

Sweden

PS

2003–2005

57

31/26

No

75

SBF, AC

CTV = GTV + (1–2)

5–10 in TP; 10 in LP

45/66/45

3

2 days

LA, 6MV, 5–9 NCB or CB

Yes

112.5/211.2/112.5/161.9

36

93

Fakiris (2009) [10]

U. S

PS

2003–2008

34

36

NR

No

NR

SBF

CTV = GTV

TP: 5; LP: 10

60/75/60

66/82.5/66

3

NR

LA, 10–12 NCB

No

180/262.5/180/221.3

211.2/309.4/211.2/260.3

50.2

88.1

88.1

Takeda (2009) [11]

Japan

RS

2001–2007

63

40/23

Both

78

NR

Long-scan-time CT

6–8

50/62.5/50

5

Total 5–7 days

LA, 10 arc dynamic conformal

Yes

100/140.6/100/120.3

31

93.7

Baba (2010) [12]

Japan

PS

2004–2008

85

37

54/31

29/8

Both

77

78

Body Fix

Normal breathing, expiratory holding and inspiratory holding CTs, CTV = GTV

TP: 5; LP: 10

48/48/38.4

52/52/41.6

4

4

Twice per week

LA, 3 CB and 4 NCB

Yes

105.6/105.6/75.3/90.4

119.6/119.6/84.9/102.2

26

81

74

Ricardi (2010) [13]

Italy

PS

2003–2007

62

52/10

No

73.7

SBF

Long-scan-time CT, CTV = GTV

TP: 5; LP: 10

45/56.25/45

3

2 days

LA, 6–8 NCB

Yes

112.5/161.7/112.5/137.1

28

87.8

Timmerman (2010) [14]

U. S

PS

2004–2006

55

21/34

No

72

NR

4D-CT, CTV = GTV

TP: 5; LP: 10

54/67.5/54

3

Total 1.5–2 weeks

LA, 4–10 MV

No

151.2/219.4/151.2/185.3

34.4

97.6

Shirata (2012) [15]

Japan

RS

2005–2009

45

NR

NR

77

Vacuum pillow

Long-scan-time CT, ITV = GTV + 0 ~ 5

PTV = ITV + 5–10

48/48/43.2

4

4–6 days

LA, NCB dynamic arcs

Yes

105.6/105.6/89.9/97.7

30.4

100

Rosen (2014) [16]

U. S

PS

2005–2010

20

59

33/46

No

73

Body FIX, AC

4D-CT, PET-CT fusion for GTV, 6–10 mm margin

6

48/48/48

60/6060

5

1 day

Tomotherapy

NR

105.6/105.6/105.6/105.6

132/132/132/132

27

85.0

96.6

Lindberg (2015) [17]

Sweden

PS

2003–2005

57

26/31

No

75.2

SBF, AC

CTV = GTV + 1 ~ 2

TP: 5; LP: 10

45/67.2/45

3

NR

LA, 6MV

NR

112.5/217.7/112.5/165.1

41.5

91.8

Nagata (2015) [18]

Japan

PS

2004–2008

164

120/44

Both

78

NR

CTV = GTV

5

48/48/42

4

Total 4–8 days

LA, NCB or dynamic arc

Yes

105.6/105.6/86.1/95.9

47/67**

86.6

Navarro-Martin (2016) [19]

Spain

PS

2008–2012

38

36/2*

No

74

Thermoplastic masks

4D-CT

6

54/70.2/54

3

8–14

LA, 7 NCB or arcs

Yes

151.2/234.4/151.2/192.8

36

94

Shaverdian (2016) [20]

U. S

RS

2009–2013

110

NR

NR

75

Vacuum pillow

4D-CT, MIP

TP: 3; LP: 6

54/65.6/54

3

2 days

LA, CB and NCB

Yes

151.2/209.0/151.2/180.1

28.9

100

Tsurugai (2016) [21]

Japan

RS

2005–2014

155

99/56

Both

77

SBF, AC

Long-scan-time CT

5

48/48/42.2

4

NR

LA, 6–7 NCB

Yes

105.6/105.6/86.7/96.2

34.7

90.5

Sun (2017) [22]

U. S

PS

2005–2013

65

32/33

Both

71.8

Deep inspiration breath hold

4D-CT, MIP

NR

50/–/50

4

NR

LA, 6–12 CB or NCB

NR

112.5/–/112.5/–

86

95.4

Cummings (2018) [23]

U. S

PS

2007–2015

65

98

30/35

44/54

NR

76

77

ITV > 0.5 cm: respiratory gating

CTV = GTV, 4D-CT

5

30/–/30

50/50/40

1

5

1 fraction per day

LA, 11 NCB

No

120/120/–/–

100/100/72/86

24

40

84.0

82.8

karasawa (2018) [24]

Japan

RS

2003–2010

56

39/17

No

79

SBF

Long-scan-time CT, margin 5 mm

5

48/48/42

4

Total 1 week

LA, 6MV

Yes

105.6/105.6/86.1/95.9

127

78.2

Ma (2018) [25]

U. S

RS

2007–2015

94

47/47

NR

76.2

Expiration breath hold or free breathing 4D-CT

CTV = GTV,

4D-CT

5

60/80/60

3

2 days

LA, 11 NCB

NR

180/293.3/180/236.7

29.3

73.5

Raghavan (2018) [26]

U. S

RS

2009–2014

140

25/24

No

70 + 

Vacuum pillow

4D-CT, MIP

TP: 3; LP: 6

54/67.5/54

3

2 days

LA, 6MV

No

151.2/219.4/151.2/185.3

38.8

93.4

Bezjak (2019) [27]

Canada

PS

2009–2013

38

33

15/23

13/20

No

71

72

NR

4D-CT

4D-CT: 5; Non 4D-CT: TP: 5; LP: 10

57.5/71.9/57.5

60/75/60

5

2–3 days

LA, 3D-CRT or IMRT

Yes

123.6/175.3/123.6/149.5

132/187.5/132/195.8

37.9

86.7

84.7

Nicosia (2019) [28]

Italy

RS

2010–2017

44

29/15

No

75

NR

4D-CT

4–5

30/31.6/30

1

NR

LA, 7–9 beams

NR

120/131.5/120/125.7

34

87.8

Devpura (2021) [29]

U. S

PS

NR

55

29/26

No

75

Free breathing

4D-CT, CTV = GTV

TP: 3; LP: 6

48/50.5/48

4

2 days

LA

Yes

105.6/114.3/105.6/114.3

24

93

Ryuno (2022) [30]

Japan

RS

2010–2019

96

61/35

Both

77

Vacuum pillow, RTS

4D-CT

2

54/72/54

3

NR

Cyberknife

NR

151.2/244.8/151.2/198

27

95.8

  1. N number CTV clinical target volume, ITV internal target volume, PTV planning target volume, THC Tissue heterogeneity correction, m months, PS prospective study, SBF stereotactic body frame, AC abdominal compression, TP transversal plane, LP longitudinal plane, LA linear accelerator, NCB noncoplanar beam, CB coplanar beam, U. S. United States, NR Not reported, RS retrospective study, MIP maximum intensity projection, GTV gross target volume, 4D-CT four-dimensional computed, 3D-CRT three-dimensional conformal radiotherapy, IMRT intensity modulated radiotherapy, RTS respiratory tracking system
  2. *4 patients did not report gender
  3. **The inoperable group and the operable group reported the follow-up time respectively